Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-29
DOI
10.1016/j.apsb.2021.11.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
- (2021) Bianca Oresta et al. Science Translational Medicine
- Ultrasound-Augmented Mitochondrial Calcium Ion Overload by Calcium Nanomodulator to Induce Immunogenic Cell Death
- (2021) Pan Zheng et al. NANO LETTERS
- Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade
- (2021) Seong Dong Jeong et al. Advanced Science
- HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
- (2021) Petr Chytil et al. Journal of Personalized Medicine
- Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
- (2021) Baicheng Wei et al. NANO LETTERS
- Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade
- (2021) Minglu Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking
- (2020) Lian Li et al. ADVANCED FUNCTIONAL MATERIALS
- Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
- (2020) Hongzhang Deng et al. NANO LETTERS
- HPMA-based polymeric conjugates in anticancer therapeutics
- (2020) Sarita Rani et al. DRUG DISCOVERY TODAY
- A novel mitochondrial targeted hybrid peptide modified HPMA copolymers for breast cancer metastasis suppression
- (2020) Qiuyi Li et al. JOURNAL OF CONTROLLED RELEASE
- Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death
- (2020) Jun Li et al. Science China-Chemistry
- Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma
- (2020) Yifei Yin et al. Nano Today
- PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
- (2019) Reem Saleh et al. Cancers
- Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure
- (2019) Chao Chen et al. ADVANCED MATERIALS
- Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death
- (2019) Cao Dai Phung et al. JOURNAL OF CONTROLLED RELEASE
- An NIR-Fluorophore-Based Therapeutic Endoplasmic Reticulum Stress Inducer
- (2018) Yang Wang et al. ADVANCED MATERIALS
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Chemotherapy induces enrichment of CD47+/CD73+/PDL1+immune evasive triple-negative breast cancer cells
- (2018) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TFAM is a novel mediator of immunogenic cancer cell death
- (2018) Minghua Yang et al. OncoImmunology
- A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
- (2018) Shabnam Shaabani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-ligand 1 Signaling Pathway
- (2018) Tianyu Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration
- (2018) Jen-Yang Tang et al. SEMINARS IN CANCER BIOLOGY
- Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
- (2017) Chunlin Li et al. Cancer Immunology Research
- Immunosuppression associated with chronic inflammation in the tumor microenvironment
- (2015) Dingzhi Wang et al. CARCINOGENESIS
- ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
- (2014) Abhishek D. Garg et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells
- (2012) Arthur A. Hurwitz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An Involvement of Oxidative Stress in Endoplasmic Reticulum Stress and Its Associated Diseases
- (2012) Bidur Bhandary et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Octaarginine- and Octalysine-modified Nanoparticles Have Different Modes of Endosomal Escape
- (2008) Ayman El-Sayed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Evaluation of a Well-defined HPMA Copolymer–Dexamethasone Conjugate for Effective Treatment of Rheumatoid Arthritis
- (2008) Xin-Ming Liu et al. PHARMACEUTICAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started